Latin America as a Scientific Contributor

For decades, Latin America's role in global biomedical research was largely that of a participant — providing clinical trial populations or adopting knowledge generated elsewhere. That is changing. Institutions across Brazil, Mexico, Argentina, Chile, and Colombia are producing original research of international significance, with particular strengths in areas where the region's unique disease burden creates both need and expertise.

Areas of Research Strength

Tropical and Infectious Diseases

LATAM researchers are global leaders in studying diseases endemic to the region: dengue, Zika, Chagas disease, leishmaniasis, and more recently, COVID-19 variants. Brazil's Fiocruz institute, one of the most respected public health research organizations in the world, has driven landmark work in vaccine development, epidemiology, and disease surveillance.

Genomics and Personalized Medicine

The genetic diversity of Latin America — shaped by indigenous, European, African, and Asian ancestries — makes the region invaluable for genomic research. Understanding how genetic variation influences disease risk and drug response in mixed-ancestry populations is a frontier where LATAM researchers are making essential contributions that the global scientific community cannot replicate elsewhere.

Chronic Disease Epidemiology

With the region experiencing a major epidemiological transition toward non-communicable diseases, LATAM researchers are producing important longitudinal studies on diabetes, cardiovascular disease, obesity, and mental health — findings that have relevance far beyond the region.

Neglected Tropical Diseases (NTDs)

Research institutions in Brazil, Colombia, and Venezuela continue to advance diagnostics, treatment protocols, and prevention strategies for NTDs that receive limited attention from research centers in wealthier nations.

Key Research Institutions

  • Fiocruz (Brazil): A world-class public health and biomedical research institute, encompassing hospitals, laboratories, and a vaccine manufacturer.
  • UNAM (Mexico): Mexico's National Autonomous University hosts one of the largest and most productive biomedical research communities in the region.
  • CONICET (Argentina): Argentina's national research council supports thousands of researchers across biomedical, pharmaceutical, and health sciences.
  • Universidad de Chile / UC Chile: Chilean research universities have developed strong programs in oncology, neuroscience, and public health.

Challenges Facing LATAM Researchers

  1. Funding volatility: Science budgets are often the first cut when governments face fiscal pressure, creating instability for long-term research programs.
  2. Brain drain: Talented researchers are frequently recruited by better-funded institutions in North America or Europe.
  3. Publication and language barriers: Research published in Spanish or Portuguese receives less international citation, underrepresenting the region's scientific output.
  4. Regulatory and ethical frameworks: Clinical research regulation varies significantly across countries, complicating multi-country trial design.

Building Regional Scientific Capacity

International collaborations — with NIH, WHO, Wellcome Trust, and European research councils — are helping build LATAM scientific capacity while ensuring research priorities align with regional needs. Regional networks like the PAHO's RIMSA and the Ibero-American Network of Science and Technology are also strengthening cross-border scientific cooperation.

The growth of Latin American biomedical science is not just a regional story. For global health, having strong, well-funded research institutions embedded in diverse, high-burden populations is a scientific asset the world cannot afford to underinvest in.